-+ 0.00%
-+ 0.00%
-+ 0.00%

Marvel Biosciences Grants 59,693 Deferred Share Units to Directors in Lieu of Cash Fees

PUBT·11/18/2026 22:03:19
Listen to the news
Marvel Biosciences Grants 59,693 Deferred Share Units to Directors in Lieu of Cash Fees
  • Marvel Biosciences awarded 59,693 deferred share units to its three independent directors in lieu of cash payment for directors' fees.
  • The deferred share units will all vest on November 18, 2027.
  • Vested deferred share units will be settled upon directors' separation from service and expire 365 days following separation.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Marvel Biosciences Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202611181702NEWSFILECNPR____20261118_324730_1) on November 18, 2026, and is solely responsible for the information contained therein.